Our results are consistent with those of Bremer et al., showing no difference in acute and late cutaneous toxicity after treatment for early breast cancer with 3D-CRT between a group of ten patients carrying a known ATM PV leading to a frameshift or missense [20]. Here, ATM is linked to breast cancer.